CompletedNot Applicable

Clinical Efficacy of Respiratory Pediatric Physiotherapy on a Child With Hospital Treated Pneumonia

Mexico88 participantsStarted 2018-02-03

Plain-language summary

The accumulation of secretions in the bronchopulmonary air network promotes the detriment of respiratory functions generating hypoxia and causing a decrease in the cardiac output requiring the use of mechanical ventilation and hemodynamic support. It is intended to control the accumulation of secretions by means of Respiratory Pediatric Physiotherapy (RPP) and to evaluate its effectiveness counting on biological plausibility.

Who can participate

Age range1 Year – 7 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients from the Hospital Infantil de México Federico Góme with diagnosis of pneumonia (considering the diagnostic criteria of the WHO and the Guidelines for Nosocomial Pneumonia from the infectiology department.
✓. Patients aged 0 to 8 years old.
✓. A minimum HS of 72 hours.
✓. Having informed consent.
✓. Not having had previous RPP treatment.

Exclusion criteria

✕. Presenting a fever state for more than three days. Performing physiotherapy increases the body's peripheral temperature.
✕. Presenting an oxygen saturation below 80%.
✕. Requiring mechanical ventilation.
✕. Hemodynamic instability.
✕. Presenting systemic inflammatory response syndrome.
✕. Inotropic support.
✕. Anatomical variants in the thorax.
✕. Unstable thorax.

What they're measuring

Respiratory difficulty

Timeframe: 5 days

Trial details

NCT IDNCT06174454

SponsorHospital Infantil de Mexico Federico Gomez

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-08-04

View on ClinicalTrials.gov More Pneumonia Childhood trials